Pathway-scale variant effect mapping reveals the importance of cell context
Authors:
- Jessica J. SimonJSJessica J. Simon
- Sriram PendyalaSPSriram Pendyala
- A. Felicia AdebanjoAAA. Felicia Adebanjo
- Daniel L. HolmesDHDaniel L. Holmes
- Madeline WalshMWMadeline Walsh
- Allyssa J. VandiAVAllyssa J. Vandi
- Ziyu R. WangZWZiyu R. Wang
- Melinda K. WheelockMWMelinda K. Wheelock
- Jordan L. OpsahlJOJordan L. Opsahl
- Aman ShihoraASAman Shihora
- Abbye E. McEwenAbbye E. McEwen
- Nahum T. SmithNSNahum T. Smith
Preprint
Abstract
Variation alters inherent protein properties like thermodynamic stability and catalytic activity, and these intrinsic effects are shaped by the cellular environment. The RAS–MAPK signaling pathway typifies this interplay, with hundreds of proteins acting in concert through regulated states and interactions to transduce signals. To explore how cell context influences variant effects, we measured the abundance and pathway activity of 186,676 variants across 17 MAPK proteins in human cells under diverse conditions, for a total of 503,099 measurements. We discovered 14,412 dominant negative variants, nearly all previously unknown, that disrupt specific domains or interaction interfaces while preserving other functions. MAPK dominant negatives occur at conserved positions and are depleted from the human population relative to other activity-altering variants, representing a distinct constraint on the human genome. Modulating chaperone activity exposed previously hidden effects of genetic variation on protein abundance in human cells, revealing the HSP90 dependence of 67% of missense variants across the pathway. Combining hundreds of experimental and predicted protein interaction structures with variant effect data distinguished functional from non-functional interaction interfaces and revealed how their disruption affected function. We resolved the overlapping KRAS-LZTR1-SOS1 interface into partner-specific and shared binding determinants, identified allosteric networks supporting each interaction, and uncovered distinct mechanisms by which variants promote LZTR1-mediated degradation. Thus, we measure variant effects at pathway scale in human cells, illuminating fundamental MAPK pathway signaling mechanisms and demonstrating that cellular context profoundly shapes the effect of most variants.Keywords
Funding Information
- Chan Zuckerberg Initiative (CZIF2024-010284)
This publication has 111 references indexed in Scilit:
- Identification of affinity-optimized peptide binders of a viral protease for chemical genetic applicationsBioorganic & Medicinal Chemistry Letters, 2025
- PRKN-linked familial Parkinson’s disease: cellular and molecular mechanisms of disease-linked variantsCellular and Molecular Life Sciences, 2024
- Molecular determinants of Hsp90 dependence of Src kinase revealed by deep mutational scanningProtein Science, 2023
- The molecular genetics of RASopathies: An update on novel disease genes and new disordersAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2022
- Massively parallel characterization of CYP2C9 variant enzyme activity and abundanceThe American Journal of Human Genetics, 2021
- The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactionsProtein Science, 2020
- Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain MutationsCancer Cell, 2018
- A simple method for displaying the hydropathic character of a proteinJournal of Molecular Biology, 1982
- Protein volume in solutionProgress in Biophysics and Molecular Biology, 1972
- The characterization of amino acid sequences in proteins by statistical methodsJournal of Theoretical Biology, 1968